CEBP Alpha/CEBPA Rekombinanter Antikörper

CEBP Alpha/CEBPA Rekombinant Antikörper für IF/ICC, FC (Intra), Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

IF/ICC, FC (Intra), Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

242101C9

Kat-Nr. : 84668-4-PBS

Synonyme

CEBP alpha, CEBPA, CEBP, CCAAT/enhancer-binding protein alpha, C/EBPα



Geprüfte Anwendungen

Produktinformation

84668-4-PBS bindet in IF/ICC, FC (Intra), Indirect ELISA CEBP Alpha/CEBPA und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen CEBP Alpha/CEBPA fusion protein Ag29947
Vollständiger Name CCAAT/enhancer binding protein (C/EBP), alpha
Berechnetes Molekulargewicht 38 kDa
Beobachtetes Molekulargewicht 40-45 kDa
GenBank-ZugangsnummerNM_004364
Gene symbol CEBPA
Gene ID (NCBI) 1050
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

CEBPA and its isoforms play important roles in lineage determination and gene activation in a variety of cell types by activating transcription from lineage-specific promoters. CEBPA is a DNA-binding protein that recognizes two different motifs: the CCAAT homology common to many promoters and the enhanced core homology common to many enhancers. In hematopoiesis, C/EBPa is a key factor in driving the development of myeloid cells interacting with a variety of factors, including c-Myc, PU.1, and microRNAs. It can also form heterodimers with the related proteins CEBP-beta and CEBP-gamma. The encoded protein has been shown to bind to the promoter and modulate the expression of the gene encoding leptin which plays an important role in body weight homeostasis. CEBPA can interact with CDK2 and CDK4, thereby inhibiting these kinases and causing growth arrest in cultured cells. Several pathways have been implicated as the means by which CEBPA mediates cell cycle arrest and proliferation, including p21, cyclin-dependent kinases and the E2F complex via c-Myc.